A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Laterre PF, Sánchez-García M, van der Poll T, de la Rosa O, Cadogan KA, Lombardo E, François B

Journal title: BMC Pulm Med

Journal publisher: BioMed Central

Published year: 2020

Published pages: 20(1):309

DOI identifier: 10.1186/s12890-020-01324-2

ISSN: 1471-2466